- 2023.12.13Information
EVENT: EME will join Antibody Engineering & Therapeutics 2023 as an associate sponsor.
- 2023.09.27Research News
[Research news] : EME successfully constructs CAR-T with VHH antibodies, The in vitro experiment showed the secretion of IL-2 from EME’s VHH-based CAR-T cell.
- 2023.08.18Information
Northwestern University experts published to Nature “Mega-scale experimental analysis of protein folding stability in biology and design” in July 2023. The research team utilized EME’s cnvK linker for development of cDNA display proteolysis method.
- 2023.07.28Press Release
EME entered into a comprehensive collaboration agreement with Kao for Multiple Infectious Diseases with Utilizing PharmaLogical™ VHH.
- 2023.05.28Information
【Overseas Event】EME will join Bio international Convention 2023
- 2023.02.07Press Release
EME and ASKA Announce Collaboration Agreement on Creating Novel PharmaLogical® VHH to address an unmet medical need in Obstetrics and Gynecology
- 2022.12.26Information
About business during the year-end and New Year holidays
- 2022.09.26Information
【Event】EME will exhibit at Japan Healthcare Venture Summit (JHVS) 2022
- 2022.06.02Information
【Overseas Event】EME will join Bio international Convention 2022
- 2022.04.21Information
【Overseas Event】EME will attend 18th Annual PEGS BOSTON Conference & Expo
